Thomas Gwise

Analysis of racial and ethnic disparities in multiple myeloma US FDA drug approval trials

Bindu Kanapuru, Laura L. Fernandes, Lola A. Fashoyin‐Aje et al. · Blood Advances · 2022 · 56 citations · Full text

Medicine, Oncology, Clinical Epidemiology +12

FDA's Approval of the First Biosimilar to Bevacizumab

Sandra J. Casak, Steven J. Lemery, Jee Young Chung et al. · Clinical Cancer Research · 2018 · 36 citations

Pharmacy, Oncology, Pharmacokinetics +17

Use of Nonconcurrent Common Control in Master Protocols in Oncology Trials: Report of an American Statistical Association Biopharmaceutical Section Open Forum Discussion

Rajeshwari Sridhara, Olga Marchenko, Qi Jiang et al. · Statistics in Biopharmaceutical Research · 2021 · 35 citations · Full text

Medicine, Biostatistics, Oncology +12

Response Rate, Event-Free Survival, and Overall Survival in Newly Diagnosed Acute Myeloid Leukemia: US Food and Drug Administration Trial-Level and Patient-Level Analyses

Kelly J. Norsworthy, Xin Gao, Chia‐Wen Ko et al. · Journal of Clinical Oncology · 2021 · 34 citations · Full text

Medicine, Biostatistics, Oncology +14

Eligibility criteria and Enrollment of a Diverse Racial and Ethnic population in Multiple Myeloma Clinical Trials

Bindu Kanapuru, Laura L. Fernandes, Andrea Baines et al. · Blood · 2023 · 23 citations · Full text

Medicine, Hematology, Oncology +15